Kapil Cotex Ltd PB

PB Ratio of Kapil Cotex Ltd

Image

Skybiotech Healthcare Limited

NSE: SKYBIOTECH

PB Ratio

2.8

Last updated on: Oct 06, 2026

Key Highlights

  • The latest PB Ratio of Skybiotech Healthcare Limited is 2.8.
  • The PB ratio of the Skybiotech Healthcare Limited is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors The P/B Ratio of Skybiotech Healthcare Limited changed from 3.5 on March 2025 to 3.7 on March 2026 . This represents a CAGR of 2.82% over 2 years .

Historical P/B Ratio of Skybiotech Healthcare Limited

No data available

Company Fundamentals for Skybiotech Healthcare Limited

Market Cap

22 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

2.8

Day’s High

116.2

Day’s Low

116.2

DTE

1.1

ROE

-14.0

52 Week High

218.2

52 Week Low

113.9

ROCE

-10.0

Market Price of Skybiotech Healthcare Limited

1M

1Y

3Y

5Y

Monitoring Skybiotech Healthcare Limited share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Oct 2026116.2
30 Sep 2026116.2
29 Sep 2026116.2
28 Sep 2026113.9
25 Sep 2026114
24 Sep 2026115.6
23 Sep 2026115.05
22 Sep 2026115.05
21 Sep 2026115
18 Sep 2026120

SWOT Analysis Of Skybiotech Healthcare Limited

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Skybiotech Healthcare Limited

Asset Value vs Market Value of Skybiotech Healthcare Limited

Market Value

₹ 0

Asset Value

₹ 0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

PB Ratio of Skybiotech Healthcare Limited Explained

₹22.25

Market cap

₹42

Book Value per Share

2.8X

PB Ratio

Historical Market Cap of Skybiotech Healthcare Limited

Market Cap

No data available

* All values are in ₹ crore

Historical Revenue, EBITDA and Net Profit of Skybiotech Healthcare Limited

Revenue

EBITDA

Net Profit

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Skybiotech Healthcare Limited News Hub

Kapil Cotex reports standalone net profit of Rs 0.25 crore in the June 2024 quarter

Net profit of Kapil Cotex reported to Rs 0.25 crore in the quarter ended June 2024 as against net lo

Read more

16 Aug 24

Kapil Cotex to conduct AGM

Kapil Cotex announced that the 41th Annual General Meeting (AGM) of the company will be held on 30 S

Read more

18 Sept 24

Kapil Cotex announces board meeting date

Kapil Cotex will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powered

Read more

11 Nov 24

Kapil Cotex reports standalone net profit of Rs 0.01 crore in the September 2024 quarter

Net profit of Kapil Cotex remain constant at Rs 0.01 crore in the quarter ended September 2024 and a

Read more

15 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Skybiotech Healthcare Limited

What is the PB ratio of Skybiotech Healthcare Limited?

The current PB ratio of Skybiotech Healthcare Limited is 2.78. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Skybiotech Healthcare Limited stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Skybiotech Healthcare Limited. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Skybiotech Healthcare Limited calculated?

The PB ratio of Skybiotech Healthcare Limited is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Skybiotech Healthcare Limited?

A high PB ratio suggests that Skybiotech Healthcare Limited’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Skybiotech Healthcare Limited?

A low PB ratio of Skybiotech Healthcare Limited may indicate that the stock is undervalued or it is facing financial difficulties.

Can Skybiotech Healthcare Limited PB Ratio change over time?

Yes, the PB ratio of Skybiotech Healthcare Limited can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions